In contrast, T cells were reactive to the TP53 mutation‐derived peptides in HCC 25 (TP53 R90S) and HCC 448 (TP53 R90S) with HLA‐C binding (Figure 4F). Here, HLA-C is linked to hepatocellular carcinoma.